Title
Category
Credits
Event date
Cost
Integrating GLP-1 RAs Into T2DM Treatment
  • Diabetes Mellitus (DM)
  • 0.50 AMA PRA Category 1 Credit™
$0.00
In this educational initiative, meet 4 patients with type 2 diabetes mellitus. Review the cases and decide which of these patients could benefit from glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy. Then, review the glycemic and extraglycemic effects of GLP-1 RAs and explore strategies for addressing common patient concerns with GLP-1 RA treatment.